← Back to headlines
New Drug Nearly Doubles Life Expectancy for Pancreatic Cancer Patients
A newly approved treatment in the United States has shown remarkable results, nearly doubling survival rates for individuals diagnosed with pancreatic cancer.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
